Summary
The provided FDA label excerpts support the pregnancy-discontinuation instruction for both ALTACE and VOSTALLY. However, the overall AI output contains many additional ramipril/pain/interaction claims not supported by the supplied label text, and the label excerpts provided only cover fetal toxicity/discontinuation in pregnancy.
Category Scores
Accurate Statements
When pregnancy is detected, discontinue the drug (ALTACE/VOSTALLY) as soon as possible due to fetal toxicity.
ALTACE 5.6 Fetal Toxicity; ALTACE 8.1 Pregnancy; VOSTALLY 5.1 Fetal Toxicity; VOSTALLY 8.1 Pregnancy; Boxed warning text for both products
Unsupported Statements
Ramipril is an ACE inhibitor.
Not supported by the provided label excerpts (only fetal toxicity/discontinuation in pregnancy text was supplied).
Acetaminophen is usually the go-to option with ramipril for pain relief, does not typically raise bleeding risk with ramipril, and does not typically affect kidney blood flow the way some other painkillers do when used with ramipril.
Not supported by the supplied prescribing information excerpts (only fetal toxicity/discontinuation content provided).
NSAIDs (ibuprofen/naproxen/diclofenac) can reduce kidney blood flow with ramipril, may increase risk of kidney problems, can raise blood pressure when used with ramipril, can reduce how well the ACE inhibitor works, and should be avoided for routine use with ramipril.
Not supported by the supplied prescribing information excerpts.
Cold/flu combo products may contain NSAIDs and may lead to accidentally doubling up NSAIDs.
Not supported by the supplied prescribing information excerpts.
Frequent high-dose painkiller use increases risk even if a drug is occasionally used.
Not supported by the supplied prescribing information excerpts.
Occasional single doses of ibuprofen or naproxen are sometimes used by people taking ramipril.
Not supported by the supplied prescribing information excerpts.
Choosing acetaminophen first is described as a safer approach for pain in people taking ramipril.
Not supported by the supplied prescribing information excerpts.
If an NSAID is needed in a person taking ramipril, it is best to confirm with a pharmacist or prescriber.
Not supported by the supplied prescribing information excerpts.
People on ramipril with kidney disease, heart failure, older age, dehydration, or use of diuretics should confirm before using an NSAID.
Not supported by the supplied prescribing information excerpts.
Low-dose aspirin for heart protection may be prescribed alongside ramipril; bleeding risk depends on dose and other medicines; for aspirin for pain, dose should be confirmed with a clinician or pharmacist.
Not supported by the supplied prescribing information excerpts.
If a person taking ramipril develops signs of kidney problems after taking a pain medicine, they should seek medical advice promptly, including specific example symptoms (decreased urination, unusual swelling) and bleeding symptoms (severe stomach pain/black stools, vomiting blood) and shortness of breath.
Not supported by the supplied prescribing information excerpts.
Interaction risk with ramipril increases if a person also uses diuretics, potassium supplements, salt substitutes with potassium, or other blood pressure medicines.
Not supported by the supplied prescribing information excerpts.
Contradictions
Important Omissions
Any discussion of dosing/administration, contraindications, full warnings/precautions, adverse reactions, monitoring, or detailed interaction statements from the prescribing information (beyond fetal toxicity discontinuation) to support the numerous ramipril/pain/interaction claims.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The only on-label claim present in the provided label excerpt context is the pregnancy discontinuation instruction, which is directly supported. The many additional non-supported interaction/pain statements cannot be validated against the supplied label text.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Most ramipril interaction/pain/analgesic claims are not supported by the prescribing information excerpts provided (which cover only fetal toxicity/discontinuation in pregnancy).
Suggested Improvement
Limit claims to label-supported content from the provided sections (e.g., fetal toxicity boxed warning and pregnancy discontinuation) or provide the corresponding label sections for interactions, warnings/precautions, and specific population guidance before making additional safety/interaction assertions.